APA aipamena

Bairey, O., Amiel, A., Yust-Katz, S., Gurion, R., & Siegal, T. (2019). P05.04 Phase 2 open-label study of maintenance treatment with ibrutinib following first line methotrexate-based immuno-chemotherapy in elderly patients with primary CNS lymphoma (PCNSL). Neuro Oncol.

Chicago Style aipamena

Bairey, O., A. Amiel, S. Yust-Katz, R. Gurion, and T. Siegal. "P05.04 Phase 2 Open-label Study of Maintenance Treatment With Ibrutinib Following First Line Methotrexate-based Immuno-chemotherapy in Elderly Patients With Primary CNS Lymphoma (PCNSL)." Neuro Oncol 2019.

MLA aipamena

Bairey, O., et al. "P05.04 Phase 2 Open-label Study of Maintenance Treatment With Ibrutinib Following First Line Methotrexate-based Immuno-chemotherapy in Elderly Patients With Primary CNS Lymphoma (PCNSL)." Neuro Oncol 2019.